首页|期刊导航|世界中医药杂志（英文版）|Pudilan Anti-inflammatory Oral Liquid and Organic Acid Component from Taraxaci Herba Attenuate Allergic Asthma in Young Mice Through Toll-like Receptor 2/Toll-like Receptor 4 Signaling Pathway

Pudilan Anti-inflammatory Oral Liquid and Organic Acid Component from Taraxaci Herba Attenuate Allergic Asthma in Young Mice Through Toll-like Receptor 2/Toll-like Receptor 4 Signaling Pathway

Yu-Zhi Mao Liang Feng Chen-Zi Li Wei-Quan Bu Bing Yang Ya-Ping Chen Jun Liu Jing Zhao E Sun Xiao-Bin Jia

世界中医药杂志（英文版）2024，Vol.10Issue(3)：294-302,9.

世界中医药杂志（英文版）2024，Vol.10Issue(3)：294-302,9.DOI:10.4103/wjtcm.wjtcm_64_24

Pudilan Anti-inflammatory Oral Liquid and Organic Acid Component from Taraxaci Herba Attenuate Allergic Asthma in Young Mice Through Toll-like Receptor 2/Toll-like Receptor 4 Signaling Pathway

Yu-Zhi Mao ¹Liang Feng ¹Chen-Zi Li ²Wei-Quan Bu ³Bing Yang ²Ya-Ping Chen ²Jun Liu ⁴Jing Zhao ⁴E Sun ³Xiao-Bin Jia²

作者信息

1. State Key Laboratory of Natural Medicines,School of Traditional Chinese Pharmacy,China Pharmaceutical University,Nanjing,China||College of Pharmacy,Xuzhou Medical University,Xuzhou,China
2. State Key Laboratory of Natural Medicines,School of Traditional Chinese Pharmacy,China Pharmaceutical University,Nanjing,China
3. Third Clinical Medical College,Nanjing University of Chinese Medicine,Nanjing,China
4. Jumpcan Pharmaceutical Co.,Ltd.,Jiangsu,Taixing,China
折叠

摘要

关键词

Allergic asthma/organic acid component/Pudilan anti-inflammatory oral liquid/Taraxaci Herba/toll-like receptor 2/toll-like receptor 4

Key words

Allergic asthma/organic acid component/Pudilan anti-inflammatory oral liquid/Taraxaci Herba/toll-like receptor 2/toll-like receptor 4

引用本文复制引用

Yu-Zhi Mao,Liang Feng,Chen-Zi Li,Wei-Quan Bu,Bing Yang,Ya-Ping Chen,Jun Liu,Jing Zhao,E Sun,Xiao-Bin Jia..Pudilan Anti-inflammatory Oral Liquid and Organic Acid Component from Taraxaci Herba Attenuate Allergic Asthma in Young Mice Through Toll-like Receptor 2/Toll-like Receptor 4 Signaling Pathway[J].世界中医药杂志（英文版）,2024,10(3):294-302,9.

基金项目

This study was funded by the National Key R and D Program of China(2018YFC1706900,2018YFC1706902),"Double First-Class"University project of China Pharmaceutical University(CPU2018GF07,CPU2018PZQ19),Jiangsu Provincial Administration of Traditional Chinese Medicine(YB201819),the Project Program of State Key Laboratory of Natural Medicines,China Pharmaceutical University(No.SKLNMZZ202025). （2018YFC1706900,2018YFC1706902）

世界中医药杂志（英文版）

OACSTPCD

ISSN：2311-8571

访问量0

下载量0

段落导航